104 related articles for article (PubMed ID: 10564124)
1. Impaired cerebral vasodilator responses to NO and PDE V inhibition after subarachnoid hemorrhage.
Sobey CG; Quan L
Am J Physiol; 1999 Nov; 277(5):H1718-24. PubMed ID: 10564124
[TBL] [Abstract][Full Text] [Related]
2. Effect of subarachnoid hemorrhage on dilatation of rat basilar artery in vivo.
Sobey CG; Heistad DD; Faraci FM
Am J Physiol; 1996 Jul; 271(1 Pt 2):H126-32. PubMed ID: 8760167
[TBL] [Abstract][Full Text] [Related]
3. Selective effects of subarachnoid hemorrhage on cerebral vascular responses to 4-aminopyridine in rats.
Quan L; Sobey CG
Stroke; 2000 Oct; 31(10):2460-5. PubMed ID: 11022080
[TBL] [Abstract][Full Text] [Related]
4. Cerebrovascular dysfunction after subarachnoid haemorrhage: novel mechanisms and directions for therapy.
Sobey CG
Clin Exp Pharmacol Physiol; 2001 Nov; 28(11):926-9. PubMed ID: 11703398
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of 4-aminopyridine on responses of the basilar artery to nitric oxide.
Sobey CG; Faraci FM
Br J Pharmacol; 1999 Mar; 126(6):1437-43. PubMed ID: 10217538
[TBL] [Abstract][Full Text] [Related]
6. Zaprinast, a type V phosphodiesterase inhibitor, dilates capacitance vessels in anaesthetised rats.
Ng SS; Pang CC
Eur J Pharmacol; 1998 Jun; 351(3):323-8. PubMed ID: 9721024
[TBL] [Abstract][Full Text] [Related]
7. Type V phosphodiesterase expression in cerebral arteries with vasospasm after subarachnoid hemorrhage in a canine model.
Inoha S; Inamura T; Ikezaki K; Nakamizo A; Amano T; Fukui M
Neurol Res; 2002 Sep; 24(6):607-12. PubMed ID: 12238630
[TBL] [Abstract][Full Text] [Related]
8. The role of cGMP hydrolysing phosphodiesterases 1 and 5 in cerebral artery dilatation.
Kruuse C; Rybalkin SD; Khurana TS; Jansen-Olesen I; Olesen J; Edvinsson L
Eur J Pharmacol; 2001 May; 420(1):55-65. PubMed ID: 11412839
[TBL] [Abstract][Full Text] [Related]
9. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
[TBL] [Abstract][Full Text] [Related]
10. Relaxant effect of sildenafil in the rabbit basilar artery.
Salom JB; Burguete MC; Pérez-Asensio FJ; Castelló-Ruiz M; Torregrosa G; Alborch E
Vascul Pharmacol; 2006 Jan; 44(1):10-6. PubMed ID: 16325476
[TBL] [Abstract][Full Text] [Related]
11. Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage.
Atalay B; Caner H; Cekinmez M; Ozen O; Celasun B; Altinors N
Neurosurgery; 2006 Nov; 59(5):1102-7; discussion 1107-8. PubMed ID: 17143244
[TBL] [Abstract][Full Text] [Related]
12. Persistence of the nitric oxide-dependent vasodilator pathway of cerebral vessels after experimental subarachnoid hemorrhage.
Vatter H; Weidauer S; Dias S; Preibisch C; Ngone S; Raabe A; Zimmermann M; Seifert V
Neurosurgery; 2007 Jan; 60(1):179-87; discussion 187-8. PubMed ID: 17228267
[TBL] [Abstract][Full Text] [Related]
13. Effect of subarachnoid hemorrhage on cerebral vasodilatation in response to activation of ATP-sensitive K+ channels in chronically hypertensive rats.
Sobey CG; Heistad DD; Faraci FM
Stroke; 1997 Feb; 28(2):392-6; discussion 396-7. PubMed ID: 9040696
[TBL] [Abstract][Full Text] [Related]
14. Sildenafil increases cerebrovascular reactivity: a transcranial Doppler study.
Brenner S
Neurology; 2006 May; 66(9):1455-6; author reply 1455-6. PubMed ID: 16682690
[No Abstract] [Full Text] [Related]
15. Impairment of intracerebral arteriole dilation responses after subarachnoid hemorrhage. Laboratory investigation.
Park IS; Meno JR; Witt CE; Chowdhary A; Nguyen TS; Winn HR; Ngai AC; Britz GW
J Neurosurg; 2009 Nov; 111(5):1008-13. PubMed ID: 19408973
[TBL] [Abstract][Full Text] [Related]
16. Contribution of 20-HETE to vasodilator actions of nitric oxide in the cerebral microcirculation.
Alonso-Galicia M; Hudetz AG; Shen H; Harder DR; Roman RJ
Stroke; 1999 Dec; 30(12):2727-34; discussion 2734. PubMed ID: 10583004
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase 5 inhibition restores impaired ACh relaxation in hypertensive conduit pulmonary arteries.
Oka M
Am J Physiol Lung Cell Mol Physiol; 2001 Mar; 280(3):L432-5. PubMed ID: 11159025
[TBL] [Abstract][Full Text] [Related]
18. E4021, a selective phosphodiesterase 5 inhibitor, potentiates the vasodilator effect of inhaled nitric oxide in isolated perfused rat lungs.
Ohnishi M; Oka M; Muramatsu M; Sato K; Kira S; Fukuchi Y
J Cardiovasc Pharmacol; 1999 Apr; 33(4):619-24. PubMed ID: 10218733
[TBL] [Abstract][Full Text] [Related]
19. Impaired vascular responses of insulin-resistant rats after mild subarachnoid hemorrhage.
Institoris A; Snipes JA; Katakam PV; Domoki F; Boda K; Bari F; Busija DW
Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2080-7. PubMed ID: 21421821
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase type 5 inhibition enhances vasorelaxation caused by nitroprusside in guinea pig intact heart and isolated aorta.
Stowe F; Novalija E
J Cardiovasc Pharmacol; 2000 Aug; 36(2):162-8. PubMed ID: 10942156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
